Study sheds more light on survival of patients with gastric cancer

Leipzig (Germany), May 8: Researchers found that patients with gastric cancer who get zolbetuximab have longer lives.

Related Keywords

Germany ,Leipzig ,Sachsen ,German ,Florian Lordick ,University Cancer Center Leipzig ,Professor Florian Lordick ,University Cancer Center ,